Die asphärische Blaulichtfilter-IOL AcrySof IQ im Vergleich mit der AcrySof SA60AT

Background

The aspheric optic design of intraocular lenses (IOL) aims to minimize postoperative ocular spherical aberration (SA). The effect of a standardized IOL asphericity depends on IOL power, pupil diameter, and corneal asphericity. The impact of these factors was investigated in a comparative study.

Material and methods

In a prospective study, 70 eyes with the aspheric blue light filter IOL AcrySof IQ (Alcon) were compared to 36 eyes with the conventional AcrySof SA60AT (Alcon). Six weeks after uneventful phacoemulsification the following parameters were assessed: visual acuity, higher order aberrations, pupil diameter, and corneal asphericity.

Results

The comparison of 42 eyes in a normal dioptric range with the IQ IOL (22.4±2.0 D) to 20 eyes with the control lens of similar IOL power (22.0±2.7 D) showed no different visual outcome. For a 5-mm pupil SA was calculated at 0.04 (±0.05) µm for the IQ IOL and 0.20 (±0.06) µm for the AcrySof SA60AT. Also for a 4-mm pupil SA was significantly lower in eyes with the IQ lens. A separate evaluation of 28 eyes which needed very high or low IOL power revealed a similar postoperative SA for the IQ IOL. The greatest difference of SA between the two IOLs was found in hyperopic eyes with higher IOL power. The corneal asphericity (Q value) showed significant correlation to postoperative ocular SA.

Conclusions

The aspheric AcrySof IQ reduces postoperative SA significantly compared to a conventional IOL even with smaller pupils and independent of IOL power. The assessment of corneal asphericity enables an individual estimation of postoperative SA.     

Postoperative optical aberrations in eyes implanted with AcrySof spherical and aspheric intraocular lenses

PURPOSE: To evaluate and compare optical and visual quality of eyes implanted with spherical and aspheric intraocular lenses (IOLs). METHODS: Twenty eyes of 17 patients were implanted with the AcrySof Natural IQ aspheric IOL (SN60WF) and 20 eyes of 15 patients were implanted with the AcrySof Natural spherical IOL (SN60AT). Photopic monocular distance best spectacle-corrected visual acuity (BSCVA) was recorded at 6 months postoperatively. Corneal aberrations were measured with the CSO Eyetop topographer, and ocular aberrations were measured with a Hartmann-Shack aberrometer for a 6-mm pupil. Ocular spherical aberration was computed for different pupil diameters (3, 4, 5, and 6 mm). RESULTS: No statistically significant differences were found between the BSCVA of the AcrySof IQ IOL (0.023 +/- 0.004 logMAR) and AcrySof Natural IOL (0.031 +/- 0.003 logMAR) (P = .15). The corneal higher order aberrations showed no statistically significant differences between groups (P > .1). However, spherical aberration and higher order ocular aberrations in the AcrySof IQ eyes were lower than eyes implanted with the AcrySof Natural IOL (P < .01). A statistically significant increase in the spherical aberration coefficient with pupil diameter was found only for the spherical IOL group (P = .0023). Statistically significant differences in the spherical aberration coefficient were found between groups at all pupil diameters (P < .001). CONCLUSIONS: A significant reduction in ocular spherical aberration was noted after AcrySof IQ IOL implantation at all pupil diameters compared to the spherical IOL, although photopic BSCVA between groups remained similar.     

Contrast sensitivity and higher order aberrations in eyes implanted with AcrySof IQ SN60WF and AcrySof SN60AT intraocular lenses

PURPOSE: To evaluate the efficacy of the aspheric optic of the AcrySof IQ SN60WF intraocular lens (IOL) in decreasing spherical and total higher order aberrations and improving contrast sensitivity after cataract surgery compared to the spheric AcrySof SN60AT. METHODS: Fifty-two eyes of 36 patients were evaluated at the University of Texas Southwestern Medical Center at Dallas 3 to 6 months after phacoemulsification with implantation of the AcrySof IQ SN60WF (27 eyes) or AcrySof SN60AT (25 eyes) IOL. Eyes with previous surgery or ocular pathology were excluded. RESULTS: Eyes implanted with the AcrySof IQ SN60WF had less total higher order and spherical aberrations than AcrySof SN60AT-implanted eyes at pupils of 4 mm (0.14+/-60.06 vs 0.18+/-0.04 microm and -0.01+/-0.03 vs 0.09+/-0.03 microm, respectively), 5 mm (0.24+/-0.07 vs 0.34+/-0.08 microm and 0.03+/-0.02 vs 0.23+/-0.08 microm, respectively), and 6 mm (0.42+/-0.13 vs 0.67+/-0.12 microm and 0.08+/-0.04 and 0.46+/-0.09 microm, respectively), (P<.05 for all), with similar mean coma, trefoil, and 5th order aberrations. AcrySof SN60WF eyes showed better contrast sensitivity than AcrySof SN60AT eyes at 12 and 18 cycles per degree (cpd) under mesopic conditions (1.65+/-0.23 vs 1.51+/-0.25 and 1.22+/-0.21 vs 1.01+/-0.19, respectively), and at 18 cpd under glare (1.12+/-0.30 vs 0.87+/-0.31, respectively) (P<.05). Photopic contrast sensitivity was similar in both groups. The two groups had comparable mean age, axial length, IOL power, and postoperative mesopic and photopic pupil sizes. CONCLUSIONS: Compared to a spheric optic, the aspheric design of the AcrySof IQ SN60WF reduces spherical aberration, especially under larger pupil sizes, and improves mesopic contrast sensitivity at higher frequencies with and without glare.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

黄色非球面人工晶状体植入术后视觉质量的临床分析

目的 观察老年性白内障患者植入黄色非球面人工晶状体AcrySof IQ术后对比敏感度和眩光敏感度.方法 前瞻性临床对照研究.56例(56只眼)老年性白内障患者,随机分为三组,分别植入非球面人工晶状体AerySof IQ(SN60wF)及球面人工晶状体Acrysof Natural(SN60AT)、Acrysof (SA60AT).术后2月行最佳矫正视力、像差及对比敏感度检查.结果 三组患者术后最佳矫正视力≥20/30.IQ组与球面晶状体组比较,球差均显著性减少(P<0.05),高阶像差及彗差无统计学意义(P0.05).在非眩光状态下,低频时IQ组的对比敏感度(10g值)显著高于球面晶状体组(P<0.05),中频2.5deg时IQ组的对比敏感度显著高于SA60AT组(P<0.05).在眩光状态下,低频时IQ组的对比敏感度也显著高于球面晶状体组(SN60AT组:P<0.01,SA60AT组:6.3degrees P<0.01,4.0degrees P<0.05).结论 非球面人工晶状体可以减少球面像差,提高低频尤其是眩光状态下的对比敏感度从而获得更好的视觉质量.滤蓝光晶状体与普通晶状体比较对比敏感度差异无统计学意义,不能明显改善视功能.     

Improvements in vision-related quality of life with AcrySof IQ SN60WF aspherical intraocular lenses

PURPOSE: To compare vision-related quality of life and higher-order aberrations (HOAs) with an aspherical intraocular lens (IOL) (AcrySof IQ SN60WF) and a conventional spherical IOL (AcrySof SA60AT) (both Alcon) after phacoemulsification. SETTING: Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan, Republic of China. METHODS: Sixty-five patients were prospectively randomized to receive an Alcon AcrySof IQ SN60WF IOL (30 eyes) or an AcrySof SA60AT IOL (35 eyes). All patients had a complete ophthalmologic examination including uncorrected visual acuity, best spectacle-corrected visual acuity (BSCVA), and wavefront analysis preoperatively and 3 months postoperatively. Patients also completed the National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to evaluate vision-related quality of life. RESULTS: The mean postoperative BSCVA (logMAR) was 0.09 +/- 0.07 (SD) in the aspherical IOL group and 0.12 +/- 0.08 in the spherical IOL group; the difference was not statistically significant. Spherical aberrations were statistically significantly lower in the aspherical IOL group (mean 0.12 +/- 0.23 microm) than in the spherical IOL group (mean 0.33 +/- 0.20 microm) (P = .001). Both IOL types improved most aspects of patients' vision-related quality of life. The aspherical IOL group had clinically significant improvement on more NEI VFQ-25 subscales, although the difference between groups in vision-related quality of life was not statistically significant. CONCLUSION: Eyes with the aspherical AcrySof IQ SN60WF IOL had reduced HOAs and spherical aberrations compared with eyes with the spherical AcrySof SA60AT IOL; however, there were no statistically significant differences in visual acuity or vision-related quality of life between groups.     

非球面人工晶状体植入术后视觉质量对比分析

目的:评价3种非球面人工晶状体(AcrySof SN60WF、TecnisZ9001和KS-3Ai)植入术后的视觉质量。方法:采用前瞻性随机对照研究方法,收集我院老年性白内障手术患者88例126眼,平均年龄67.3±8.7岁,将入选患者按植入不同的人工晶状体(Intraocular lens,IOL)随机分为4组:AcrySofSN60WF(IQ)组(23例33眼)、TecnisZ9001组(23例33眼)、KS-3Ai组(20例29眼),SN60AT球面人工晶状体组为对照组(22例31眼)。术后随访3mo,观察指标:裸眼视力(uncorrected visual acuity,UCVA)及最佳矫正视力(best corrected visual acuity,BCVA),眼压,等效球镜度数,角膜Q值,瞳孔直径,6mm全眼球总高阶像差及四阶球差均方根值(root mean square,RMS),夜光、昼光及夜眩光3种视觉条件下的对比敏感度(contrast sensitivity,CS)。结果:术后各组的UCVA、BCVA、等效球镜度数和瞳孔直径均无统计学差异。总高阶像差和四阶球差RMS:非球面组低于球面组,差异具有统计学意义(P<0.05);非球面组间比较无统计学差异。术后角膜Q值与球差成正相关(r=0.183,P<0.05)。术后对比敏感度:与球面IOL相比,IQ,Tecnis可提高术后3种视觉条件下的CS,KS-3Ai可提高术后夜光、夜眩光两种视觉条件下的CS;非球面IOL组间比较,IQ组在昼光、夜眩光视觉条件下的CS好于Tecnis组和KS-3Ai组,TECNIS组和KS-3Ai组之间在3种视觉条件下均无统计学差异。结论:3种非球面IOL均可有效地减少术眼的总高阶像差和四阶球差。3种非球面IOL均可以提高术眼术后的CS,IQ组在昼光、夜眩光视觉条件下的CS与Tecnis组和KS-3Ai组相比较差异具有统计学意义,Tecnis组和KS-3Ai组之间在3种视觉条件下的CS均无统计学差异。     

超声乳化白内障吸除术前角膜球差对相对个性化非球面人工晶状体植入的影响

目的 探讨根据患者超声乳化白内障吸除术前角膜球差植入合适的非球面人工晶状体(IOL)使其术后全眼球差为零方法的可行性.方法 前瞻性病例系列研究.对46例(57只眼)年龄相关性白内障患者行超声乳化白内障吸除联合非球面IOL植入术前1 d,利用iTrace视觉功能分析仪测量6.0 mm瞳孔直径的角膜球差(Z40),为使患者术后总球差接近于零,对角膜球差小于0.100 μm者植入Sofport Advanced OpticIOL(AO组,10只眼),0.100～0.235 μm者植入AcrySof IQIOL(IQ组,20只眼),大于0.235 μm者植入Tecnis ZA9003 IOL(Tecnis组,27只眼).患者均行3.2 mm透明角膜切口的超声乳化白内障吸除联合非球面IOL植入术,术后3个月观察患者的裸眼视力、最佳矫正视力、6.0 mm瞳孔直径时的全眼及内眼(主要是IOL)球差.采用t检验和方差分析对获得的数据进行统计学分析.结果 术后所有患者6.0 mm瞳孔直径时的全眼球差为(0.015±0.056)μm[AO组:(0.081±0.013)μm;IQ组:(0.006±0.038)μm;Tecnis组:(0.007±0.070)μm];所有患者术后全眼球差的预测值与实际值的差异无统计学意义(t=1.983,P=0.052)(Sofport:t=1.957,P=0.082;AcrySofIQ:t=0.030,P=0.976;Tecnis:t=2.031,P=0.053);所有患者全眼球差的预测值与实际值的差值为(0.014±0.044)μm[AO组:(0.006±0.012)μm;IQ组:(-0.000±0.037)μm;Tecnis组:(0.027 ±0.052)μm;F=2.626,P=0.082].术后3组患者的裸眼视力、最佳矫正视力比较,差异均无统计学意义(F=0.901,P=0.412;F=2.416,P=0.099).结论 根据患者术前的角膜球差植入合适的非球面IOL,术后均能够获得较满意的目标球差,为相对个性化植入非球面IOL方法的应用提供临床依据.     

白内障手术植入球面和非球面人工晶状体后视觉质量的比较

目的 评估白内障手术植入负球差设计的非球面折叠式人工晶状体(Intraocularlen,IOL)后的视觉质量.方法 取112例(152只眼)白内障超声乳化手术患者按数字表法被分为三组,第一组植入TecnisZ9003IOL(美国 AMO 公司),第二组植入AcrysofIQIOL(美国Alcon公司),第三组植入HQIOL(法国Hexavision公司).于术后一周、一月、三月分别检测裸眼视力、最佳矫正视力,无眩光及有眩光环境下的白天夜晚对比敏感度,同时检测全眼的球差、第三、第四、第五阶像差均方根(root mean square,RMS)、总高阶像差(higher-order aberration,HOA)RMS以及总像差(total ocular aberration,TOA)RMS.结果 术后三次随访三组患者的裸眼视力和最佳矫正视力差异均没有统计学意义.术后一周、一月时三组白天对比敏感度未见显著差异,术后一月、三月时TecnisZ9003组和AcrysofIQ组的夜间对比敏感度在中、低空间频率上明显好于HQ组,同时术后三月时该两组的白天对比敏感度亦好于HQ组,差异均具有统计学意义(P＜0.05).另外,术后三次随访TecnisZ9003组和AcrysofIQ组全眼的球差、RMS4均低于HQ组,在术后一月、三月时HOA较HQ组低,同时术后三次随访在瞳孔直径6mm大小时TOA亦较低,差异均有统计学意义(P＜0.05).结论 植入负球差设计的非球面人工晶状体可提高白内障患者术后对比敏感度,降低球差和高阶像差,获得更好的视觉质量.     

白内障手术植入球面和非球面人工晶状体后视觉质量的比较

目的 评估白内障手术植入负球差设计的非球面折叠式人工晶状体(Intraocularlen,IOL)后的视觉质量.方法 取112例(152只眼)白内障超声乳化手术患者按数字表法被分为三组,第一组植入TecnisZ9003IOL(美国 AMO 公司),第二组植入AcrysofIQIOL(美国Alcon公司),第三组植入HQIOL(法国Hexavision公司).于术后一周、一月、三月分别检测裸眼视力、最佳矫正视力,无眩光及有眩光环境下的白天夜晚对比敏感度,同时检测全眼的球差、第三、第四、第五阶像差均方根(root mean square,RMS)、总高阶像差(higher-order aberration,HOA)RMS以及总像差(total ocular aberration,TOA)RMS.结果 术后三次随访三组患者的裸眼视力和最佳矫正视力差异均没有统计学意义.术后一周、一月时三组白天对比敏感度未见显著差异,术后一月、三月时TecnisZ9003组和AcrysofIQ组的夜间对比敏感度在中、低空间频率上明显好于HQ组,同时术后三月时该两组的白天对比敏感度亦好于HQ组,差异均具有统计学意义(P＜0.05).另外,术后三次随访TecnisZ9003组和AcrysofIQ组全眼的球差、RMS4均低于HQ组,在术后一月、三月时HOA较HQ组低,同时术后三次随访在瞳孔直径6mm大小时TOA亦较低,差异均有统计学意义(P＜0.05).结论 植入负球差设计的非球面人工晶状体可提高白内障患者术后对比敏感度,降低球差和高阶像差,获得更好的视觉质量.     

A comparison of higher order aberrations in eyes implanted with AcrySof IQ SN60WF and AcrySof SN60AT intraocular lenses

PURPOSE: To evaluate the efficacy of AcrySof SN60WF aspheric intraocular lens (IOL) in decreasing spherical aberration and total higher order aberrations (HOAs) after cataract surgery compared to the spherical SN60AT lens. METHODS: Wavefront analysis was conducted on 28 eyes of 28 patients that underwent un-complicated phacoemulsification with implantation of either SN60WF (15 eyes) or SN60AT lenses (13 eyes). Eyes with a history of uveitis, retinal diseases, and previous surgery were excluded. RESULTS: SN60WF eyes had less mean absolute spherical aberration than SN60AT eyes both at 4 mm (0.04+/-0.03 vs 0.11+/-0.03 RMS, p<0.0001) and 6 mm pupils (0.09+/-0.04 vs 0.43+/-0.12 RMS, p<0.0001). Mean total HOAs was lower in the SN60WF group at 6 mm pupils (0.44+/-0.14 vs 0.56+/-0.13 RMS, p=0.0274), while no difference was seen at 4 mm pupils (0.20+/-0.10 vs 0.25+/-0.08 RMS, p=0.160). There were no clinically significant differences between the SN60WF and SN60AT IOLs both at 4 and 6 mm pupils in terms of coma (0.16+/-0.07 vs 0.18+/-0.09 RMS, p=0.514 and 0.25+/-0.12 vs 0.23+/-0.12 RMS, p=0.664) and trefoil (0.14+/-0.09 vs 0.10+/-0.05 RMS, p=0.167 and 0.28+/-0.12 vs 0.23+/-0.07 RMS, p=0.199). There were no differences be-tween groups in mean age, axial length, postoperative spherical equivalent, IOL power, or corneal curvature. CONCLUSIONS: An aspheric posterior optic IOL design with thinner center effectively reduces the positive ocular spherical aberration observed in the pseudophakic and elderly eyes, especially at larger pupillary diameters (6 mm), with no notable increase in coma. However, reduction in total ocular HOAs was only significant at 6 mm pupils.